| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 03/29/2007 | WO2006135925A3 Methods to reduce oxalate concentration by administration of oxalate oxidase crystals |
| 03/29/2007 | US20070072916 Amino ceramide-like compounds and therapeutic methods of use |
| 03/29/2007 | US20070072849 Tricyclic quinolinone and tricyclic quinoline androgen receptor modulator compounds and methods |
| 03/29/2007 | US20070072835 Method of preparing and use of prodrugs of betulinic acid derivatives |
| 03/29/2007 | US20070072291 Dedifferentiated, programmable stem cells of monocytic origin, and their production and use |
| 03/29/2007 | US20070072261 Nucleic acids encoding PAK5 polypeptidesm and methods of use thereof |
| 03/29/2007 | US20070072236 Novel type II Na/Pi cotransporters and type II Na/Pi cotransporter expression regulatory factors |
| 03/29/2007 | US20070071824 Treatment of mucositis using N-acetylcysteine |
| 03/29/2007 | CA2623576A1 System and method for the prevention and treatment of bacterial and fungal infections including urinary tract infections (uti) using a hypohalous acid compositions |
| 03/28/2007 | EP1767633A1 Novel polypeptide useful for diagnosis and treatment of cancer |
| 03/28/2007 | EP1767531A1 Medicinal compositions containing 6-hydroxybenzbromarone or salts thereof |
| 03/28/2007 | EP1767208A1 Remedy for hyperactive bladder |
| 03/28/2007 | EP1767207A2 Solid Oral Dosage Forms |
| 03/28/2007 | EP1767206A2 Solid Oral Dosage Forms |
| 03/28/2007 | EP1500397B1 Adsorbents for oral administration, remedies or preventives for kidney diseases and remedies or preventives for liver diseases |
| 03/28/2007 | CN1938226A Method for producing spherical activated carbon |
| 03/28/2007 | CN1938037A Adsorbent for oral administration and therapeutic agent or prophylactic agent for kidney disease and therapeutic agent or prophylactic agent for liver disease |
| 03/28/2007 | CN1938008A Sustained-release preparations |
| 03/28/2007 | CN1935839A Analogues of glp-1 |
| 03/28/2007 | CN1935768A Vegeta tive female sex hormone eudesmane compound, and its preparing method and use |
| 03/28/2007 | CN1935260A Human antibodies that bind human tnfalpha |
| 03/28/2007 | CN1935252A Oral liquid for treating prostatic disease |
| 03/28/2007 | CN1935225A Chinese medicine for treating renal failure and urotoxia, and its preparing method |
| 03/28/2007 | CN1935204A Health care medicinal liquor for nourishing kidney and strengthening yang |
| 03/28/2007 | CN1935194A Chinese medicine composition for treating nephroma |
| 03/28/2007 | CN1935173A Animal medicament with expelling toxin bycooling, purging liver to brighten vision and its preparing method |
| 03/28/2007 | CN1935170A Animal medicament with nourishing qi to invigorate spleen, tonifying kidney to relieve mental strain and its preparing method |
| 03/28/2007 | CN1935166A Health-care medicinal liquor for nourishing kidney and strengthening yang |
| 03/28/2007 | CN1935128A Use of pogostemonis alkane type sesquiterpene compound as vegetative female sex normone |
| 03/28/2007 | CN1307181C Condensed heterocyclic succimide compounds as androgen receptor modulators and their analog |
| 03/28/2007 | CN1307175C Triazolo-quinolin derivatives useful as adenosine receptor ligands |
| 03/28/2007 | CN1307174C Imidazoquinoline derivatives |
| 03/28/2007 | CN1307172C 喹唑啉酮衍生物 Quinazolinone derivative |
| 03/28/2007 | CN1307158C Substituted 2-pyrrole cyclohexan-1,4-diamine derivatives |
| 03/28/2007 | CN1307150C Hydroxy tetrahydro-naphthalenylurea derivatives |
| 03/28/2007 | CN1306964C Decoy composition for treating and preventing inflammatory disease |
| 03/27/2007 | USRE39530 Dimethyl-{[2-(2-methylbenzyloxy)cyclohexyl]phenylmethyl}-amine; analgesically active, treatment of pain, local anaesthetic, antiarrhythmic, antiemetic cardiovascular diseases, urinary incontinence, diarrhea, pruritus, alcohol, drug or medicament dependency, inflammations |
| 03/27/2007 | US7196201 For therapy and prophylaxis of metabolic disorders, gastrointestinal disorders, viral disorders, inflammatory disorders, diabetes, obesity, hyperlipidemia, dermatological or mucous membrane disorders, psoriasis, intestinal distress, constipation, autoimmune disorders, encephalomyelitis |
| 03/27/2007 | US7196118 Amidino compounds useful as nitric oxide synthase inhibitors |
| 03/27/2007 | US7196104 (2-substituted-4-yl-thiazole)-urea-1-pyridine-2-yl derivative effective for prophylaxis and treatment of diseases, such as cell proliferation or apoptosis mediated diseases |
| 03/27/2007 | US7196099 Compounds and compositions as cathepsin inhibitors |
| 03/27/2007 | US7196098 Quinuclidine derivatives and medicinal compositions containing the same |
| 03/27/2007 | US7196090 Nitrogen compounds such as 1-cyclopentyl-3-(2,6-difluoro-3,5-dimethoxy-phenyl)-7-(4-dimethylamino -butylamino)-1H-pyrimido (4,5-d)pyrimidin-2-one used as cyclin-dependent and tyrosine kinase enzymes inhibitors; anticarcinogenic agents |
| 03/27/2007 | US7196080 Respiratory system disordeers; chronic obstructive pulminary disease |
| 03/27/2007 | US7196076 Androgen receptor modulators and methods of use thereof |
| 03/27/2007 | US7195902 Expression vector comprising nucleotide sequences coding JNK activating phosphatase for use identifying modulator for treatment of inflammatory, arthritic, cardiovascular, respiratory cell proliferative and liver disorders |
| 03/27/2007 | US7195870 Diagnosis of diseases associated with gene regulation |
| 03/27/2007 | US7195785 Complex mixtures exhibiting selective inhibition of cyclooxygenase-2 |
| 03/27/2007 | CA2370244C Piperidine derivatives |
| 03/27/2007 | CA2326611C Substituted heterocyclic derivatives |
| 03/22/2007 | WO2007032854A1 FUSED TRICYCLIC mGluR1 ANTAGONISTS AS THERAPEUTIC AGENTS |
| 03/22/2007 | WO2007032466A1 Heterocyclic compound, and production process and use thereof |
| 03/22/2007 | WO2006081994A3 Isolation of n-butylbenzenesulfonamide, synthesis of benzenesulfonamide derivatives, and use of n-butylbenzenesulfonamide and benzenesulfonamide derivatives for the treatment of benign prostate hyperplasia and/or prostate carcinoma |
| 03/22/2007 | US20070067861 Cloning pigs using donor nuclei from differentiated cells |
| 03/22/2007 | US20070066823 CCR9 inhibitors and methods of use thereof |
| 03/22/2007 | US20070066633 Angiogenesis inhibitor; anticancer agents; antiarthritic agents; psoriasis |
| 03/22/2007 | US20070066554 Immunostimulatory nucleic acids |
| 03/22/2007 | US20070066513 photosensitizers used in the photodynamic therapy of microbial infections, tumors, pre-cancerous and proliferative pathologies and/or in the diagnosis, as well as for blood and blood derivatives sterilization |
| 03/22/2007 | US20070065868 IL-17 receptor like molecules and uses thereof |
| 03/22/2007 | US20070065517 Modafinil Pharmaceutical Compositions |
| 03/22/2007 | CA2622605A1 Heterocycle compound, and production process and application thereof |
| 03/22/2007 | CA2619419A1 Fused tricyclic mglur1 antagonists as therapeutic agents |
| 03/21/2007 | EP1764366A2 Thrombin receptor antagonists |
| 03/21/2007 | EP1764358A2 Cyclic amides as vanilloid receptor ligands and their use in treatments of inflammatory and neuropathic pain |
| 03/21/2007 | EP1764075A1 Tissue factor production inhibitor |
| 03/21/2007 | EP1453801B1 Substituted 2-amino-cycloalkanecarboxamides and their use as cysteine protease inhibitors |
| 03/21/2007 | EP1231982B1 Use of phthalazine derivatives for the treatment of neurodegenerative diseases |
| 03/21/2007 | CN1934109A Composition for solid pharmaceutical preparation of solifenacin or salt thereof |
| 03/21/2007 | CN1934100A Substituted quinazoline or pyridopyrimidine derivative |
| 03/21/2007 | CN1934073A Novel crystal of triterpene derivative |
| 03/21/2007 | CN1933823A Use of renin inhibitors in therapy |
| 03/21/2007 | CN1931338A Chinese medicine for treating urinary calculus |
| 03/21/2007 | CN1931306A Chinese medicine soft capsule for treating urinary system diseases and its prepn process |
| 03/21/2007 | CN1931302A Chinese medicine composition for treating urethral calculus and gallstones and its prepn process |
| 03/21/2007 | CN1931292A Medicine for treating urinary system diseases and its quality control method |
| 03/21/2007 | CN1931244A Chinese medicine composition for treating urinary infection |
| 03/21/2007 | CN1931228A Lysimachia herb total flavone extract and its prepn process |
| 03/21/2007 | CN1931203A Application of total asiaticoside in preparing medicine for preventing and treating membranous nephropathy |
| 03/21/2007 | CN1931188A Medicated health wine for invigorating kidney and strengthening Yang |
| 03/21/2007 | CN1931154A Slow released tolterodine tartrate microcapsule and its prepn process |
| 03/21/2007 | CN1931149A Plaster matrix of tolterodine tartrate and/or tolterodine fumarate and plaster preparing process |
| 03/21/2007 | CN1305871C Novel piperazinyl-pyrazinone derivatives for the treatment of 5-HT2a receptor-related disorders |
| 03/21/2007 | CN1305850C Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 03/21/2007 | CN1305487C Medicinal composition for treating dysuria due to benign prostatauxe and its preparation method |
| 03/21/2007 | CN1305477C Paint for treating benign prostate hyperplasia and its use |
| 03/20/2007 | US7193040 Apoptosis of rectum and prostate cancer |
| 03/20/2007 | US7192978 Pyrrolidinium derivatives |
| 03/20/2007 | US7192972 Prevention of restenosis of blood vessels after trauma, angioplasty or stenting; piperidin-2-amide derivatives; anticarcinogenic agents |
| 03/20/2007 | US7192962 Enzyme hydrolase inhibitors such as 1-ethyl-3,7-dihydro-8-((1 R,2R)-(hydroxycyclopentyl)amino)-3-(2-hydroxyethyl)-7-((3-bromo-4 -methoxyphenyl)methyl)-1H-Purine-2,6-dione, used for physiological effects |
| 03/20/2007 | US7192961 1-Carbonyl-4-(4-quinoline-)-piperazine or 1-carbonyl-4-[4-(1H-quinolin-2-{thio}one)-piperazine derivatives; retinopathy, adult respiratory distress syndrome, asthma, osteoarthritis, glomerulonephritis, psoriasis, rheumatoid arthritis, and toxic shock syndrome treatment |
| 03/20/2007 | US7192955 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 03/20/2007 | US7192940 Ether compounds |
| 03/20/2007 | US7192929 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 03/20/2007 | US7192715 Diagnostics and therapy of epstein-barr virus in autoimmune disorders |
| 03/20/2007 | US7192609 Administering to the gastrointestinal tract salt of a rare earth metal and one or more nontoxic counterions, which salt is hydrated, in an amount effective to inhibit the absorption of oxalate from the gastrointestinal tract |
| 03/20/2007 | US7192582 Human monoclonal antibodies to FC alpha receptor (CD89) |
| 03/20/2007 | US7192570 Compositions of somatostatin analogues |
| 03/15/2007 | WO2007029847A1 Bicyclic aromatic substituted pyridone derivative |
| 03/15/2007 | WO2007013078A3 Inhibition of the renin-angiotensin system for the treatment of renal, vascular and cartilage pathology |
| 03/15/2007 | US20070060647 Gene expression regulating agent |